Phreesia, Inc.

Phreesia, Inc. is a software as a service (SaaS) company that provides an integrated platform encompassing software, payments, and patient engagement solutions for healthcare organizations. Founded in 2005, the company's mission is to simplify healthcare experiences daily and foster active patient participation in their care. Phreesia's headquarters are located in Wilmington, Delaware, U.S..

The company offers a comprehensive suite of applications designed to automate and manage the patient intake process. Key offerings include digital registration, insurance verification, clinical screening, consent form management, and point-of-service payment solutions. Phreesia's platform integrates into existing provider workflows and patient interactions, serving a diverse client base that includes ambulatory practices, health systems, hospitals, and life sciences companies. Additional services extend to appointment scheduling, patient communication, telehealth integration, and revenue cycle management.

Phreesia became a publicly traded company on the New York Stock Exchange (NYSE: PHR) in July 2019. Chaim Indig, a co-founder, serves as the Chief Executive Officer, having been appointed in January 2005. Evan Roberts, also a co-founder, is the President of Provider Solutions. The company has expanded its capabilities through strategic acquisitions, including QueueDr and Insignia Health in 2021, Access eForms in August 2023, and AccessOne in September 2025. In March 2026, Phreesia announced the refinancing of a bridge loan with a new $275 million revolving credit facility, and is scheduled to release its fiscal first quarter 2027 financial results on May 27, 2026. In 2025, Phreesia facilitated over 180 million patient visits, accounting for approximately one in six visits across the United States.